Advanced search
Publication Cover
Climacteric Volume 21, 2018 - Issue 2
Submit an article Journal homepage
18,965
Views
47
CrossRef citations to date
0
Altmetric
Review

The impact of micronized progesterone on breast cancer risk: a systematic review

P. StuteDepartment of Obstetrics and Gynecology, University of Bern, Bern, Switzerland; Correspondence[email protected]
View further author information
,
L. WildtDepartment of Gynecological Endocrinology and Reproductive Medicine, Medical University of Innsbruck, Innsbruck, Austria; View further author information
&
J. NeulenClinic for Gynecological Endocrinology and Reproductive Medicine, RWTH University of Aachen, Aachen, GermanyView further author information
Pages 111-122 | Received 01 Nov 2017, Accepted 21 Dec 2017, Published online: 31 Jan 2018

Citations (47)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Pascual Garcia-Alfaro, Ignacio Rodríguez, Francesc Tresserra & Jean L. Browne. (2019) Changes in breast density during hormone treatment with transdermal estrogens alone or in combination with progesterone. Gynecological Endocrinology 35:11, pages 991-994.
Read now
A. Coquoz, C. Gruetter & P. Stute. (2019) Impact of micronized progesterone on body weight, body mass index, and glucose metabolism: a systematic review. Climacteric 22:2, pages 148-161.
Read now

Articles from other publishers (45)

Paru S. David, Talia Sobel, Sabrina Sahni, Jaya Mehta & Juliana M. Kling. (2023) Menopausal Hormone Therapy in Older Women: Examining the Current Balance of Evidence. Drugs & Aging 40:8, pages 675-683.
Crossref
Rowan T. Chlebowski & Aaron K. Aragaki. (2023) The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context. Menopause 30:4, pages 454-461.
Crossref
Silvia Federici, Marco Bonomi & Luca Persani. (2023) Management clinico e terapia sostitutiva dell’insufficienza ovarica primariaClinical management and replacement therapy of Primary Ovarian Insufficiency. L'Endocrinologo 24:1, pages 62-68.
Crossref
Amanda S. Nitschke, Helena Abreu do Valle, Lesa Dawson, Janice S. Kwon & Gillian E. Hanley. (2023) Long-Term Non-Cancer Risks in People with BRCA Mutations following Risk-Reducing Bilateral Salpingo-Oophorectomy and the Role of Hormone Replacement Therapy: A Review. Cancers 15:3, pages 711.
Crossref
Kayla Tanya Patel, Saira Adeel, Joanna Rodrigues Miragaya & Vin Tangpricha. (2022) Progestogen Use in Gender-Affirming Hormone Therapy: A Systematic Review. Endocrine Practice 28:12, pages 1244-1252.
Crossref
Silvia Federici, Giovanni Goggi, Richard Quinton, Luca Giovanelli, Luca Persani, Biagio Cangiano & Marco Bonomi. (2022) New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature. Endocrine Reviews 43:5, pages 824-851.
Crossref
JoAnn V. Pinkerton, Carolyn S. Wilson & Andrew M. Kaunitz. (2022) Reassuring data regarding the use of hormone therapy at menopause and risk of breast cancer. Menopause 29:9, pages 1001-1004.
Crossref
Petra Stute. (2022) Schon gewusst …?Saviez-vous que...?. Journal für Gynäkologische Endokrinologie/Schweiz 25:3, pages 155-157.
Crossref
O.О. Yefimenko. (2022) Menopauseal hormonal therapy and the risk of breast cancer in the light of new data. REPRODUCTIVE ENDOCRINOLOGY:66, pages 77-80.
Crossref
Megan Herson & Jayashri Kulkarni. (2022) Hormonal Agents for the Treatment of Depression Associated with the Menopause. Drugs & Aging 39:8, pages 607-618.
Crossref
Bonnie Liang, Ada S. Cheung & Brendan J. Nolan. (2022) Clinical features and prevalence of Klinefelter syndrome in transgender individuals: A systematic review. Clinical Endocrinology 97:1, pages 3-12.
Crossref
Haim A. Abenhaim, Samy Suissa, Laurent Azoulay, Andrea R. Spence, Nicholas Czuzoj-Shulman & Togas Tulandi. (2022) Menopausal Hormone Therapy Formulation and Breast Cancer Risk. Obstetrics & Gynecology 139:6, pages 1103-1110.
Crossref
Xiangyan Ruan & Jiaojiao Cheng. (2022) Interpretation of expert consensus on prevention and treatment of osteoporosis in perimenopausal and postmenopausal women. Global Health Journal 6:2, pages 80-84.
Crossref
Xiangyan Ruan & Alfred O. Mueck. (2022) Optimizing menopausal hormone therapy: for treatment and prevention, menstrual regulation, and reduction of possible risks. Global Health Journal 6:2, pages 61-69.
Crossref
JoAnn V. Pinkerton. (2022) Concerns About Compounded Bioidentical Menopausal Hormone Therapy. The Cancer Journal 28:3, pages 241-245.
Crossref
Zachary Nash, Bassel H. Al-Wattar & Melanie Davies. (2022) Bone and heart health in menopause. Best Practice & Research Clinical Obstetrics & Gynaecology 81, pages 61-68.
Crossref
Kugajeevan Vigneswaran & Haitham Hamoda. (2022) Hormone replacement therapy – Current recommendations. Best Practice & Research Clinical Obstetrics & Gynaecology 81, pages 8-21.
Crossref
Panagiotis Anagnostis, Irene Lambrinoudaki, John C Stevenson & Dimitrios G Goulis. (2022) Menopause-associated risk of cardiovascular disease. Endocrine Connections 11:4.
Crossref
Maria Alejandra Belardo, Pisula Pedro & Capalbo Olivia. (2022) Breast cancer and progestins in menopausal hormone therapy: a literature review. Obstetrics & Gynecology International Journal 13:2, pages 101-110.
Crossref
Gabriel Hobi, J. Mark Cline, Kelly F. Ethun, Cedric Simillion, Irene Keller & Petra Stute. (2022) Impact of 6 month conjugated equine estrogen versus estradiol-treatment on biomarkers and enriched gene sets in healthy mammary tissue of non-human primates. PLOS ONE 17:3, pages e0264057.
Crossref
Silvia Federici, Giovanni Goggi, Luca Giovanelli, Biagio Cangiano, Luca Persani, Marco Bonomi & Richard Quinton. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 75 93 .
Alexander Römmler. 2022. Präventionsmedizin und Anti-Aging-Medizin. Präventionsmedizin und Anti-Aging-Medizin 141 166 .
Patricia Geraghty. 2022. Each Woman’s Menopause: An Evidence Based Resource. Each Woman’s Menopause: An Evidence Based Resource 121 143 .
Valerie A Flores, Lubna Pal & JoAnn E Manson. (2021) Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment. Endocrine Reviews 42:6, pages 720-752.
Crossref
Elizabeth Marie King, Jerilynn C Prior, Neora Pick, Julie van Schalkwyk, Mary Kestler, Stacey Tkachuk, Mona Loutfy & Melanie C M Murray. (2021) Menopausal hormone therapy for women living with HIV. The Lancet HIV 8:9, pages e591-e598.
Crossref
Ursula Gobrecht-Keller. (2021) Gestagengabe in der Menopause: Was sind Unterschiede, Vorteile und Nachteile der einzelnen Präparate?Administration de progestatifs dans la ménopause: différences, avantages et inconvénients des différentes préparations. Journal für Gynäkologische Endokrinologie/Schweiz 24:2, pages 58-68.
Crossref
Louise Newson, Isaac Manyonda, Rebecca Lewis, Robert Preissner, Saskia Preissner & Ute Seeland. (2021) Sensitive to Infection but Strong in Defense—Female Sex and the Power of Oestradiol in the COVID-19 Pandemic. Frontiers in Global Women's Health 2.
Crossref
Nikki Noble. (2021) Hormone replacement therapy: update and practical prescribing. Practice Nursing 32:4, pages 148-156.
Crossref
Angela H E M Maas, Giuseppe Rosano, Renata Cifkova, Alaide Chieffo, Dorenda van Dijken, Haitham Hamoda, Vijay Kunadian, Ellen Laan, Irene Lambrinoudaki, Kate Maclaran, Nick Panay, John C Stevenson, Mick van Trotsenburg & Peter Collins. (2021) Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. European Heart Journal 42:10, pages 967-984.
Crossref
James H. Liu. (2021) What providers need to know about progestogens in hormone therapy. Menopause 28:3, pages 325-326.
Crossref
Haitham Hamoda, Nick Panay, Hugo Pedder, Roopen Arya & Mike Savvas. (2020) The British Menopause Society & Women’s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women. Post Reproductive Health 26:4, pages 181-209.
Crossref
James H. Liu, Denise R. Black, Lisa Larkin, Shelli GrahamBrian BernickSebastian Mirkin. (2020) Breast effects of oral, combined 17β-estradiol, and progesterone capsules in menopausal women: a randomized controlled trial. Menopause 27:12, pages 1388-1395.
Crossref
Donita Africander & Renate Louw-du Toit. (2020) Progestins in menopausal hormone therapy and breast cancer risk: The debate continues. Current Opinion in Endocrine and Metabolic Research 15, pages 24-30.
Crossref
Paul C.M. Piette. (2020) The pharmacodynamics and safety of progesterone. Best Practice & Research Clinical Obstetrics & Gynaecology 69, pages 13-29.
Crossref
Mingxuan Xie, Xiaoxiao Lu & Qiong Chen. (2020) Microarray expression profiling of long noncoding RNAs in the progesterone‐treated lung cancer cells. The Journal of Gene Medicine 22:10.
Crossref
Nikki Noble. (2020) Hormone replacement therapy: update and practical prescribing. Journal of Prescribing Practice 2:2, pages 91-97.
Crossref
Katrine Yare & Michael Woodward. (2020) Hormone Therapy and Effects on Sporadic Alzheimer’s Disease in Postmenopausal Women: Importance of Nomenclature. Journal of Alzheimer's Disease 73:1, pages 23-37.
Crossref
Benjamin S. Harris, Katherine C. Bishop, Jeffrey A. Kuller, Anne C. Ford, Lisa C. Muasher, Sarah E. Cantrell & Thomas M. Price. (2020) Hormonal management of menopausal symptoms in women with a history of gynecologic malignancy. Menopause 27:2, pages 243-248.
Crossref
Louise Newson & Janice Rymer. (2019) The dangers of compounded bioidentical hormone replacement therapy. British Journal of General Practice 69:688, pages 540-541.
Crossref
M. von Wolff & P. Stute. (2019) Neues und praktisch Relevantes der gynäkologischen Endokrinologie, Reproduktionsmedizin und Pränatalmedizin – Teil 2New and practically relevant aspects of gynecological endocrinology, reproductive medicine, and prenatal medicine—part 2. Gynäkologische Endokrinologie 17:3, pages 189-195.
Crossref
Linda Mayr, Dimitar Georgiev & Albena Toulev. (2019) Eine Proof-of-concept-Studie von Isoflavandiol-E55-RS-Vaginalkapseln oder Vaginalgel zur Linderung der menopausalen VaginalatrophieProof-of-Concept Study of Isoflavandiol E55-RS Vaginal Capsules or Vaginal Gel for the Alleviation of Menopausal Vaginal Atrophy. Journal für Gynäkologische Endokrinologie/Österreich.
Crossref
Xiangyan Ruan & Alfred O. Mueck. (2019) The choice of progestogen for HRT in menopausal women: breast cancer risk is a major issue. Hormone Molecular Biology and Clinical Investigation 37:1.
Crossref
Vincenzina Bruni & Francesca Pampaloni. 2019. Menstrual Cycle Related Disorders. Menstrual Cycle Related Disorders 111 142 .
Louise R Newson & Amir Lass. (2018) Effectiveness of transdermal oestradiol and natural micronised progesterone for menopausal symptoms. British Journal of General Practice 68:675, pages 499-500.
Crossref
Haim Arie Abenhaim, Samy Suissa, Laurent Azoulay, Andrea R. Spence, Nicholas Czuzoj-Shulman & Togas Tulandi. (2021) Hormone Replacement Therapy, Synthetic Progestogens, and Breast Cancer Risk. SSRN Electronic Journal.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.